[Form 4] Cel-Sci Corporation Insider Trading Activity

Rhea-AI Filing Summary

Haleon plc (LSE/NYSE: HLN) filed a Form 6-K to disclose its share capital position as of 30 June 2025. The Company has issued 8,988,533,553 ordinary shares of £0.01 each, of which 3,880,205 are held in treasury. Consequently, the number of ordinary shares carrying voting rights is 8,984,653,348. This denominator should be used by investors to determine whether their holdings trigger disclosure obligations under the FCA’s Disclosure Guidance and Transparency Rules. No other financial data, corporate actions or strategic updates were included in the filing.

Insights

Financial Analyst

TL;DR: Routine share-count update; no immediate valuation impact, but essential for regulatory threshold calculations.

The 6-K solely updates Haleon’s share count and voting rights. Treasury shares represent roughly 0.04 % of issued stock, leaving an effective float of 8.985 billion shares. Because no buy-back, capital raise, or earnings information is disclosed, the filing is operationally neutral. Nevertheless, accurate denominators are critical for institutional investors monitoring 3 % and 5 % disclosure thresholds under UK and FCA rules. Overall market impact is negligible.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

PRICHEP PATRICIA B

(Last) (First) (Middle)

8229 BOONE BLVD., SUITE 802

(Street)

VIENNA VA 22182

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CEL SCI CORP [ CVM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/30/2025		A		1,873	A	$2.29	10,747	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	Patricia Prichep	07/01/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Haleon (HLN) shares carry voting rights as of 30 June 2025?

Haleon reports 8,984,653,348 ordinary shares with voting rights.

What is Haleon’s total issued share capital reported in the Form 6-K?

Total issued capital is 8,988,533,553 ordinary shares of £0.01 each.

How many treasury shares does Haleon hold?

The company holds 3,880,205 shares in treasury.

Why is the voting-rights figure important for investors?

Investors use it as the denominator to determine when their holdings reach FCA disclosure thresholds.

What type of filing did Haleon submit?

A Form 6-K, providing an update on total voting rights and share capital.